# OnCo record fate-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/fate-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "fate-therapeutics" ;
  schema:name "Fate Therapeutics"@en ;
  schema:description "Fate Therapeutics builds iPSC-derived off-the-shelf CAR-T and CAR-NK cells (FT819, FT522) for cancer and autoimmune disease."@en ;
  schema:url <https://onco.cc/companies/fate-therapeutics/>, <https://fatetherapeutics.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-announces-presentations-2026-asco-and-eular> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/car-nk-macrophage/>, <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> .